DSG, Inc.

37 articles about DSG, Inc.

• DSG Developing Adaptive Solutions for Multiple Phase 3 Clinical Trials for COVID-19 Treatment

  5/26/2020

  DSG, Inc. is supporting two Phase 3 studies sponsored by Romark, L.C. to evaluate an investigational new drug for prevention of COVID-19 in elderly residents of long-term care facilities and healthcare workers. Given the urgent nature of the COVID-19 pandemic, getting a trial up and running fast is crucial but even more critical is to build a trial that is adaptive with all the uncertainties and challenges of the curr

• DSG’s eCaseLink 10 Redefining Digital Source ‘E-Source’ Clinical Trials

  9/17/2019

  DSG, Inc., industry leader in eClinical software and services for life sciences, announced its Version 10 electronic source system integrated with its flagship eCaseLink™ EDC, ePRO and IRT systems, is changing the game for its Phase 1 through 3 sponsor and CRO clients and partners.

• DSG to Attend 54th DIA Global Annual Meeting in Boston

  6/4/2018

  DSG, Inc. will be exhibiting at the 54th DIA Global Annual Meeting and Conference at booth 1707.

• DSG Attending Outsourcing in Clinical Trials Conference in Burlingame, Calif.

  2/12/2018

  The conference will be held from February 21-22, 2018 at the Hyatt Regency San Francisco Airport.

• CeloNova BioSciences Release: FDA Approves NanoCoated Coronary Stent System Using DSG, Inc.’s eClinical Systems

  3/23/2017

• DSG, Inc. Release: Company Accelerates Growth With Opening Of New Office In Bangalore, India

  1/20/2017

• Orbus Therapeutics Selects DSG, Inc. For EDC And IWRS In Recurrent Anaplastic Astrocytoma Clinical Study

  9/30/2016

• Company Profile For DSG, Inc.

  5/6/2016

• Supernus Pharmaceuticals Selects DSG, Inc. For EDC And IWRS In Phase III Clinical Studies On Impulsive Aggression In Pediatric Patients Treated For Attention Deficit/Hyperactivity Disorder (ADHD)

  4/1/2016

• DSG, Inc. Partners With Soligenix To Battle Cutaneous T-Cell Lymphoma

  4/7/2015

• Drug Approved In Pivotal Studies Using DSG, Inc.’s Fully Electronic Source Data

  3/3/2015

• DSG, Inc. And Opko Health, Inc. Enter Into Enterprise Licensing Agreement For Fully Integrated EDC, IWRS, Safety, And Trial Management Solution

  11/4/2014

• Romark Laboratories, L.C. Selects DSG, Inc. For Influenza Study

  3/11/2014

• Milo Biotechnology Announces DSG, Inc. Orphan Drug Designation for AAV1-FS344 for Treatment of Duchenne and Becker Muscular Dystrophy

  12/12/2012

• Auxilium Pharmaceuticals Selects DSG, Inc. as EDC Provider

  10/8/2012

• Media Invited to Meet DSG, Inc.’s Head of Clinical Data Management at SCDM 2012 Conference, Los Angeles

  9/20/2012

• Latest Innovations From DSG, Inc. Unveiled This Week at SCDM 2012

  9/18/2012

• Company Profile for DSG, Inc.

  8/24/2012

• Ariosa Diagnostics, Inc. Selects DSG, Inc. as EDC Provider

  4/23/2012

• DSG, Inc. Partners with Biotech Company to Battle Progressive and Chronic Kidney Disease

  2/1/2010